Buyback Spend for Labcorp Holdings (LH)
Buyback Spend for Labcorp Holdings (LH): headline value $450.00M · YoY +79.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingBuyback SpendSwitch metric
Latest period
$450.00M
YoY change
+79.9%
5Y CAGR
+27.3%
Peak year (2021)
$1.72B
Latest annual
$450.00M
Buyback Spend history chart for Labcorp Holdings (LH) from 1989 to 2025
Buyback Spend history table for Labcorp Holdings (LH) from 1989 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $450.00M | +79.9% | ||
| 2024 | $250.10M | -75.9% | ||
| 2023 | $1.04B | -9.6% | ||
| 2022 | $1.15B | -32.9% | ||
| 2021 | $1.72B | +1175.8% | ||
| 2020 | $134.50M | -70.1% | ||
| 2019 | $450.00M | -35.7% | ||
| 2018 | $700.00M | +107.0% | ||
| 2017 | $338.10M | +670.2% | ||
| 2016 | $43.90M | — | ||
| 2015 | $0 | -100.0% | ||
| 2014 | $269.00M | -73.5% | ||
| 2013 | $1.02B | +96.6% | ||
| 2012 | $516.50M | -19.8% | ||
| 2011 | $643.90M | +90.4% | ||
| 2010 | $338.10M | +23.8% | ||
| 2009 | $273.00M | -18.2% | ||
| 2008 | $333.60M | -63.8% | ||
| 2007 | $921.20M | +93.3% | ||
| 2006 | $476.50M | -18.4% | ||
| 2005 | $583.70M | +58.6% | ||
| 2004 | $368.10M | +137.6% | ||
| 2003 | $154.90M | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | -100.0% | ||
| 1993 | $154.20M | +16.9% | ||
| 1992 | $131.90M | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — |
Buyback Spend values are taken from Labcorp Holdings's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual buyback spend for Labcorp Holdings (LH) came in at $450.00M – surged 79.9% year-over-year.
Through 2020–2025 (5 years), Labcorp Holdings buyback spend delivered a +27.3% annualised rate; with the latest reading among the more recent periods of the dataset.
Labcorp Holdings buyback spend peaked at $1.72B in 2021; the latest annual figure is $450.00M in 2025 (73.8% below peak).
Across the available history, buyback spend reached its high of $1.72B in 2021 and its low of $0 in 1989.
Labcorp Holdings (LH) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $2.75B.
Labcorp Holdings Buyback Spend by Year
Labcorp Holdings Buyback Spend 2025: $450.00M
Labcorp Holdings buyback spend in 2025 was $450.00M, surged 79.9% from 2024.
Labcorp Holdings Buyback Spend 2024: $250.10M
Labcorp Holdings buyback spend in 2024 was $250.10M, plunged 75.9% below 2023.
Labcorp Holdings Buyback Spend 2023: $1.04B
Labcorp Holdings buyback spend in 2023 was $1.04B, declined 9.6% below 2022.
Labcorp Holdings Buyback Spend 2022: $1.15B
Labcorp Holdings buyback spend in 2022 was $1.15B, plunged 32.9% below 2021.
Labcorp Holdings Buyback Spend 2021: $1.72B
Labcorp Holdings buyback spend in 2021 was $1.72B.
See more financial history for Labcorp Holdings (LH).
Sector peers — Buyback Spend
Companies in the same sector as Labcorp Holdings, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Labcorp Holdings's buyback spend?
Latest reported buyback spend for Labcorp Holdings (LH) is $450.00M (period ending December 31, 2025).
How has Labcorp Holdings buyback spend changed year-over-year?
Labcorp Holdings (LH) buyback spend changed +79.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Labcorp Holdings buyback spend?
Labcorp Holdings (LH) buyback spend compound annual growth rate is +27.3% over the most recent 5 years available.
When did Labcorp Holdings buyback spend hit its highest annual value?
Labcorp Holdings buyback spend reached its highest annual value of $1.72B in 2021.
What was Labcorp Holdings buyback spend in 2024?
Labcorp Holdings (LH) buyback spend in 2024 was $250.10M.
What was Labcorp Holdings buyback spend in 2025?
Labcorp Holdings (LH) buyback spend in 2025 was $450.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
LH Overview
Company profile, financial tools, and key metrics
LH Revenue Counter
Earns $442.41 every second. See per minute, hour, and day.
LH Earnings Counter
Earns $27.79 per second net profit. See per minute, hour, and day.
LH Economic Scale
Exceeds West Bank and Gaza's GDP. Compare with world economies.
LH What If Invested
What if you had invested $1,000? See historical returns from any date.
LH How It Makes Money
Discover visual breakdown of $13.95B in revenue — where it comes from and where it goes.
LH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LH Daily Price Character
Balanced · 47.4% historical win rate (green days). Streaks & record days.
LH Buybacks
2.17% TTM buyback yield. Shareholder yield & SBC comparison.
LH Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LH Dividend Profile
Yield: 1.12%. Safety: 4/6. See full history.
LH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.